This inventor holds 1 USPTO granted patent. Top assignee: Covagen Ag. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: The Innovative Contributions of Michela Sillacci Melkko
Introduction
Michela Sillacci Melkko is a prominent inventor based in Schlieren, Switzerland. She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic molecules. Her work focuses on innovative solutions that address critical medical needs.
Latest Patents
Michela holds a patent for "IL-17A binding molecules and medical uses thereof." This invention relates to a polypeptide that inhibits the activity of glycosylated IL-17A. The polypeptide comprises an amino acid sequence that is crucial for its function. The invention also includes fusion constructs, compositions, and medical uses that incorporate this polypeptide. She has 1 patent to her name.
Career Highlights
Michela has built a successful career at Covagen AG, where she has been instrumental in advancing research and development in her field. Her expertise in molecular biology and biochemistry has led to groundbreaking discoveries that have the potential to improve patient outcomes.
Collaborations
Michela has collaborated with notable colleagues, including Nadja Banziger and Richard Woods. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Michela Sillacci Melkko's contributions to biotechnology exemplify the impact of innovative thinking in medicine. Her work continues to inspire future advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile